Abstract
The synthesis and proteolytic inhibitor function of two new tetrapeptides, MeOSuc-Ala-Pro-Ala-Val-CH2Cl (APAV) and MeOSuc-Ala-Pro-Ala-Leu-CH2Cl (APAL) are described. An examination of inhibitory activity using a realtime reverse transcription-polymerase chain reaction (RT-PCR) assay in the presence of proteinase K reveals that the APAL at a concentration of 0.5 mM allows a signal to be obtained for an exogenous target (“Xeno RNA”) at 29 cycles (i.e Ct = 29), whereas the MeOSuc-Ala-Ala-Pro-Val-CH2Cl (AAPV) control requires a 2-fold lower concentration (0.25 mM) to produce the same Ct. The other new analog APAV does not provide proteinase K inhibition under the same experimental conditions.
Keywords: Chloromethyl ketones, tetrapeptides, proteinase K inhibitor, serine protease, real-time RT-PCR
Letters in Organic Chemistry
Title: Synthesis and Application of New Rearranged Tetrapeptidyl Chloromethyl Ketones as Potent Proteinase K Inhibitor
Volume: 8 Issue: 1
Author(s): Anilkumar R. Kore, Muthian Shanmugasundaram and Irudaya Charles
Affiliation:
Keywords: Chloromethyl ketones, tetrapeptides, proteinase K inhibitor, serine protease, real-time RT-PCR
Abstract: The synthesis and proteolytic inhibitor function of two new tetrapeptides, MeOSuc-Ala-Pro-Ala-Val-CH2Cl (APAV) and MeOSuc-Ala-Pro-Ala-Leu-CH2Cl (APAL) are described. An examination of inhibitory activity using a realtime reverse transcription-polymerase chain reaction (RT-PCR) assay in the presence of proteinase K reveals that the APAL at a concentration of 0.5 mM allows a signal to be obtained for an exogenous target (“Xeno RNA”) at 29 cycles (i.e Ct = 29), whereas the MeOSuc-Ala-Ala-Pro-Val-CH2Cl (AAPV) control requires a 2-fold lower concentration (0.25 mM) to produce the same Ct. The other new analog APAV does not provide proteinase K inhibition under the same experimental conditions.
Export Options
About this article
Cite this article as:
R. Kore Anilkumar, Shanmugasundaram Muthian and Charles Irudaya, Synthesis and Application of New Rearranged Tetrapeptidyl Chloromethyl Ketones as Potent Proteinase K Inhibitor, Letters in Organic Chemistry 2011; 8 (1) . https://dx.doi.org/10.2174/157017811794557895
DOI https://dx.doi.org/10.2174/157017811794557895 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Structural Substrates of Semantic Memory Decline in Mild Cognitive Impairment
Current Alzheimer Research Meet Our Editor-in-Chief
CNS & Neurological Disorders - Drug Targets HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study
Current Vascular Pharmacology Comparison Between 3D Echocardiography and Cardiac Magnetic Resonance Imaging (CMRI) in the Measurement of Left Ventricular Volumes and Ejection Fraction
Current Medical Imaging Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?
Current Pharmaceutical Design Case Report: Severe Hematological, Muscle and Liver Toxicity Caused by Drugs and Artichoke Infusion Interaction in an Elderly Polymedicated Patient
Current Drug Safety Longitudinal Association between White Matter Hyperintensities and White Matter Beta-Amyloid Deposition in Cognitively Unimpaired Elderly
Current Alzheimer Research Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery <i>Withania somnifera</i> in Neurological Disorders: Ethnopharmacological Evidence, Mechanism of Action and its Progress in Delivery Systems
Current Drug Metabolism Optimization of Abrasive Wear Behavior of High Chromium Cast Iron and Hadfield Steel
Recent Patents on Mechanical Engineering Mechanisms for Antiplatelet Action of Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Effect of Aluminium Chloride Concentration on Diltiazem Hydrochloride Release from pH-sensitive Hydrogel Beads Composed of Hydrolyzed Grafted k-Carrageenan and Sodium Alginate
Current Chemical Biology Arterial Mechanics and Dynamics in Hypertension
Current Hypertension Reviews Newly Diagnosed Dementia and Increased Risk of Hemorrhagic Stroke: A Nationwide Population-based Study
Current Alzheimer Research Adhesion Molecules as Prognostic Biomarkers in Coronary Artery Disease
Current Topics in Medicinal Chemistry Imaging of Abdominal Aortic Aneurysm: The Present and the Future
Current Vascular Pharmacology Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Ultrafiltration-based Extraction and LC-MS/MS Quantification of Phenylalanine in Human Blood Sample for Metabolite Target Analysis
Current Pharmaceutical Analysis On the Role of Endothelial TRPC3 Channels in Endothelial Dysfunction and Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry